Ken Griffin Sight Sciences, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2025 May 15, 2025	SELL	$2.36 - $3.58 $46,256 - $70,168	-19,600 Reduced 56.32%	15,200 $36,000
Q4 2024 Feb 14, 2025	BUY	$3.36 - $6.18 $25,200 - $46,350	7,500 Added 27.47%	34,800 $126,000
Q3 2024 Nov 14, 2024	BUY	$5.49 - $8.31 $148,230 - $224,370	27,000 Added 9000.0%	27,300 $171,000
Q2 2024 Aug 14, 2024	SELL	$5.13 - $7.15 $9,747 - $13,585	-1,900 Reduced 86.36%	300 $2,000
Q1 2024 May 15, 2024	BUY	$4.02 - $5.89 $8,843 - $12,958	2,200 New	2,200 $11,000
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $1,688 - $2,670	200 Added 5.26%	4,000 $34,000
Q4 2022 Feb 14, 2023	BUY	$5.58 - $13.94 $21,204 - $52,972	3,800 New	3,800 $46,000

20.8M

12.7K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $203M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.